Position in LLY
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$11,748,417
+$2,738,351 QoQ
Shares Held
9,795
-0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.52%
of 13F equity value
Holder Rank
#1,165
of 4,605 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 72%
Shared 0%
None 28%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $57,599,993 across 10 Drug Manufacturers - General names. LLY ranks #2 (20.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
75,730 | $19,233,148 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
9,795 | $11,748,417 | |
| 3 | MRK |
Merck & Co., Inc.
|
62,572 | $8,040,502 | |
| 4 | ABBV |
AbbVie Inc.
|
26,085 | $6,564,029 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
77,353 | $4,457,079 | |
| 6 | BIIB |
Biogen Inc.
|
12,859 | $2,778,315 | |
| 7 | PFE |
Pfizer Inc
|
75,558 | $1,819,436 | |
| 8 | AMGN |
Amgen Inc
|
4,792 | $1,735,279 |
All Filings in LLY
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,748,417 | 9,795 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $9,010,066 | 9,796 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $18,633,878 | 17,339 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $13,678,301 | 17,927 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $13,787,547 | 17,687 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $16,359,625 | 19,808 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $13,239,028 | 17,149 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $14,782,794 | 16,686 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $13,912,974 | 15,367 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $11,517,697 | 14,805 | Shares | Sole | 2024-04-15 | |
| 2023-12-31 | $11,332,547 | 19,441 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $10,199,024 | 18,988 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $8,111,478 | 17,296 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,097,226 | 3,195 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $923,380 | 2,524 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $939,978 | 2,907 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,019,054 | 3,143 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $4,204,197 | 14,681 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $7,611,794 | 27,557 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,902,172 | 25,545 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,926,417 | 21,464 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $3,434,685 | 18,385 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||